BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6466536)

  • 1. Second look laparotomy in the management of epithelial cell carcinoma of the ovary.
    Mead GM; Williams CJ; MacBeth FR; Boyd IE; Whitehouse JM
    Br J Cancer; 1984 Aug; 50(2):185-91. PubMed ID: 6466536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of second-look laparotomy to influence survival in epithelial ovarian cancer.
    Luesley D; Lawton F; Blackledge G; Hilton C; Kelly K; Rollason T; Wade-Evans T; Jordan J; Fielding J; Latief T
    Lancet; 1988 Sep; 2(8611):599-603. PubMed ID: 2900980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
    Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
    Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-look laparotomy in ovarian cancer.
    Creasman WT
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic and therapeutic value of second-look laparotomy in advanced ovarian cancer.
    Bertelsen K; Hansen MK; Pedersen PH; Larsen G; Nyland M; Jacobsen M; Andersen JE
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1231-6. PubMed ID: 3224088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].
    Kaufmann M; Hanke J; Schmid H; Kühn W; Kubli F
    Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):581-7. PubMed ID: 3770408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal debulking following chemotherapy of advanced-stage epithelial ovarian carcinoma.
    Piura B; Glezerman M
    J Surg Oncol; 1989 Apr; 40(4):237-40. PubMed ID: 2927136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
    Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look laparotomy in ovarian carcinoma patients after 8 and after 12 courses of cisplatin-based chemotherapy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Gynecol Obstet Invest; 1989; 27(2):102-4. PubMed ID: 2731767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominopelvic irradiation for stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy.
    Menczer J; Modan M; Brenner J; Ben-Baruch G; Brenner H
    Gynecol Oncol; 1986 Jun; 24(2):149-54. PubMed ID: 3710262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
    Hoskins WJ; Rubin SC; Dulaney E; Chapman D; Almadrones L; Saigo P; Markman M; Hakes T; Reichman B; Jones WB
    Gynecol Oncol; 1989 Sep; 34(3):365-71. PubMed ID: 2548935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
    McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
    Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
    Ojeda B; Llanos M; Brunet J; Lacasta A; Alonso MC; Rueda A; Delgado E; Badía J; López López JJ
    Med Clin (Barc); 1995 Feb; 104(5):165-9. PubMed ID: 7877374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of advanced ovarian adenocarcinoma: a randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin.
    Gynecol Oncol; 1986 Jan; 23(1):1-13. PubMed ID: 3510944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
    Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
    Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.